Cerniglia et al. reported that the genetic knockdown of AKT1 reduced the oxygen consumption rate in human head and neck cancer cell lines in vitro by 30% to 40% and increased the phosphorylation level of the PDH complex at Ser293, which again suppresses PDH activity [33]. Here, AKT1 is linked to head and neck cancer.